| Original language | English |
|---|---|
| Article number | 1149 |
| Number of pages | 18 |
| Journal | Molecules |
| Volume | 25 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 4 Mar 2020 |
Funding
This research was funded by the Austrian Science Fund (FWF), grant number P28853, to C.R.K.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 301904 Cancer research
- 106002 Biochemistry
- 106023 Molecular biology
Keywords
- anticancer
- tyrosine kinase inhibitors
- crizotinib
- prodrugs
- boronic acid
- CELL LUNG-CANCER
- DOCKING
- Crizotinib
- Prodrugs
- Boronic acid
- Anticancer
- Tyrosine kinase inhibitors
Fingerprint
Dive into the research topics of 'Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver